Tag: CORO
Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19
NVX-CoV2373 Vaccine Protects Against COVID-19
Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease
Omicron Cases Pass U.S. Peak Seen With Delta
However, numbers of hospitalizations have not yet reached those higher levels
More Flights Canceled as Omicron Continues to Hit Flight Crews
Several airlines acknowledge that COVID-19 contributed significantly to recent cancellations
mRNA COVID-19 Vaccine Less Protective in Elderly With Comorbidity
At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death
Three Days of Remdesivir Cuts Risk for Severe COVID-19 in Outpatients
Three-day course of treatment results in reduced risk for hospitalization or death compared with placebo
Efficacy of Bamlanivimab for COVID-19 May Vary With Antibody Status
Further study needed to determine whether bamlanivimab could benefit patients who are negative for endogenous neutralizing antibodies
Physician’s Briefing Weekly Coronavirus Roundup
FDA Gives OK to Merck Antiviral At-Home COVID-19 Pill
Molnupiravir cut the risk for hospitalization and death in high-risk patients by 30 percent
Omicron Now Accounts for 73 Percent of New COVID-19 Cases
Rate suggests there were more than 650,000 omicron infections in the United States last week
